Quarterly ResultJul 27, 2026, 04:37 PM
Champions Oncology Record Annual Revenue $59.4M
AI Summary
Champions Oncology, Inc. announced record annual revenue of $59.4 million for its fiscal year ended April 30, 2026, alongside fourth-quarter revenue of $13.8 million, a 12% increase year-over-year. The company reported positive Adjusted EBITDA for all four quarters of fiscal year 2026, totaling $1.6 million for the full year and $158,000 for the fourth quarter. Management highlighted continued strategic investments in radiopharmaceuticals, its data platform, and commercial expansion to support future growth.
Key Highlights
- Record annual revenue reached $59.4 million for fiscal year 2026.
- Fourth quarter 2026 revenue was $13.8 million, up 12% YoY.
- Adjusted EBITDA was $158,000 for Q4 2026 and $1.6 million for fiscal year 2026.
- Achieved positive Adjusted EBITDA for all four quarters of fiscal year 2026.
- Oncology services margin improved to 51% in Q4 2026 from 41% in prior year.
- Net loss from operations for fiscal year 2026 was $1.1 million, compared to income of $4.6 million in prior year.
- Continued investment in radiopharmaceuticals, data platform, and commercial organization.
- Ended the quarter with $4.9 million in cash and no debt.
Price Impact
More from CSBR